LONDON, Nov. 19 There are considerable opportunities forimaging systems in the European life sciences industry. However, imagingmodalities vendors should focus primarily on providing cost-benefits to usersby offering the best package of technology, quality and customer value.Vendors with such a combination will be able to successfully capture themarket.
New analysis from Frost & Sullivan (http://www.healthcareIT.frost.com),European Market for Imaging in Life Sciences, finds that multi-million dollaropportunities are being created for a broad range of products. This marketwill demonstrate significant growth as the life sciences industry gears up toadopt imaging modalities for drug development.
"The adoption of imaging modalities is increasing, with sizeable marketpotential waiting to be leveraged over the next five to seven years," notesFrost & Sullivan Research Analyst Santhosh Kumar Ramaraj. "There istremendous scope and opportunity for imaging modalities vendors to provide acost-effective imaging system."
The European preclinical small animal imaging market is quite competitiveand is in the process of consolidation. This situation is pushing the needfor high-performance, low-cost imaging systems that meet the specific customerrequirements. There has also been a steady annual upswing in governmentinitiatives to promote and support animal imaging.
Currently, the price of imaging modalities is relatively high for academicresearch labs. This is having a negative impact on sales. Furthermore,longer sales cycles and funding constraints for academic research labs presentmajor challenges to sustained market expansion.
"Prospective customers have to undergo a complex process of approval fromgrant bodies and approval committees to fund the purchase of small animalimaging systems," cautions Ramaraj. "There is also a need for vendors toprovide various funding options to customers and accelerate the salesprocess."
It is important for vendors to provide clients with a range of fundingalternatives. Apprising customers of the technology, providing proof ofconcepts and offering advice, support, training and after-sales service willcreate a win-win situation. This will help maximise growth potential, whilebenefiting both vendors and buyers.
If you are interested in a virtual brochure, which provides manufacturers,end users and other industry participants with an overview of the Europeanmarket for imaging in life sciences, then send an e-mail to Patrick Cairns,Corporate Communications, at [email protected]
, with your full name,company name, title, telephone number, company e-mail address, companywebsite, city, state and country. Upon receipt of the above information, anoverview will be sent to you by e-mail.
European Market for Imaging in Life Sciences is part of the Healthcare &Life Sciences IT Growth Partnership Services Programme, which also includesresearch in the following markets: E-Clinical Trials Market, LaboratoryInformation Systems Market, Primary Care Information Systems Market, andDocument Management Systems Market. All research included in subscriptionsprovide detailed market opportunities and industry trends that have beenevaluated following extensive interviews with market participants. Interviewswith the press are available.
Frost & Sullivan, the Growth Partnership Company, partners with clients toaccelerate their growth. The company's TEAM Research, Growth Consulting andGrowth Team Membership(TM) empower clients to create a growth-focused culturethat generates, evaluates and implements effective growth strategies. Frost &Sullivan employs over 45 years of experience in partnering with Global 1000companies, emerging businesses and the investment community from more than30 offices on six continents. For more information about Frost & Sullivan'sGrowth Partnership Services, visit http://www.frost.com.European Market for Imaging in Life Sciences M2AB Contact: Patrick Cairns Corporate Communications P: +27 18 468 2315 E: [email protected]
SOURCE Frost & Sullivan